Chediak-Higashi syndrome.

Area of Science:

• Genetics and Molecular Biology
• Cell Biology
• Immunology

Background:

• Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disorder with immunodeficiency, bleeding, albinism, and neurodegeneration.
• Mutations in the lysosomal trafficking regulator (LYST) gene cause CHS, but LYST protein function remains poorly understood.
• Current treatments like stem cell transplantation do not address the neurological aspects of CHS.

Approach:

• This review synthesizes recent literature on CHS clinical manifestations and cellular defects.
• It examines the relationship between LYST mutation location and cellular phenotypes, such as granule characteristics in NK cells.
• The review explores the role of LYST in neuronal and retinal pigment epithelium cell function, particularly in autophagosome-lysosome reformation.

Key Points:

• Recent studies expand the neurological spectrum of CHS to include conditions like hereditary spastic paraplegia and parkinsonism.
• LYST mutations in different domains (ARM/HEAT vs. BEACH) correlate with distinct alterations in NK cell granule size, number, and polarization.
• LYST plays a critical role in autophagosome lysosome reformation, essential for maintaining lysosomal homeostasis in neurons.

Conclusions:

• Investigating LYST function offers insights into fundamental mechanisms of vesicular fusion and fission.
• Understanding LYST's role is crucial for developing targeted therapies for CHS, especially for its neurological complications.
• Further research into LYST is needed to fully elucidate its function in cellular processes and disease pathogenesis.